Your browser doesn't support javascript.
loading
Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine.
Münter, Rasmus; Sørensen, Erik; Hasselbalch, Rasmus B; Christensen, Esben; Nielsen, Susanne D; Garred, Peter; Ostrowski, Sisse R; Bundgaard, Henning; Iversen, Kasper K; Andresen, Thomas L; Larsen, Jannik B.
Affiliation
  • Münter R; Biotherapeutic Engineering and Drug Targeting, Department of Health Technology, Technical University of Denmark (DTU), Kgs. Lyngby 2800, Denmark.
  • Sørensen E; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
  • Hasselbalch RB; Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Copenhagen 2100, Denmark.
  • Christensen E; Biotherapeutic Engineering and Drug Targeting, Department of Health Technology, Technical University of Denmark (DTU), Kgs. Lyngby 2800, Denmark.
  • Nielsen SD; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
  • Garred P; Viru-immunology Research Unit, Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
  • Ostrowski SR; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
  • Bundgaard H; Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
  • Iversen KK; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
  • Andresen TL; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
  • Larsen JB; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
Mol Pharm ; 20(7): 3356-3366, 2023 07 03.
Article in En | MEDLINE | ID: mdl-36952227
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / COVID-19 / Hypersensitivity Limits: Adult / Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2023 Document type: Article Affiliation country: Dinamarca Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / COVID-19 / Hypersensitivity Limits: Adult / Humans Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2023 Document type: Article Affiliation country: Dinamarca Country of publication: Estados Unidos